The core activity of NovoNexile is the development and manufacture of innovative biomaterials and regenerative solutions for medicine, particularly for dentistry, orthopedics, and cosmetic surgery. The company focuses on developing advanced, flowable hydrogel transplant platforms that can be seamlessly integrated into modern, digital, and minimally invasive treatment workflows. The goal is to revolutionize regenerative medicine and set new standards in terms of precision, efficiency, and patient outcomes.